John Schultz

John is currently the Director for the Office of Technology Transfer at Houston Methodist Hospital and Research Institute. Previously, he was Acting Vice President of Business Development at Pharmozyme Inc., an engineered enzyme production platform company. Prior to that he was Vice President of Corporate Development at Intrexon Corporation where he led all corporate development activities supporting a portfolio of synthetic biology assets in the healthcare, food and industrial biotech sectors. He was also Director of Business Development at Roche Tissue Diagnostics and the Senior Vice President of Licensing and Strategic Development at Clinical Data Inc. a drug development (vilazodone) and laboratory services provider of patient testing and contract DNA sequencing services for pharma, which was acquired by Forest Laboratories. John has also worked in various general management, sales and marketing positions for BioChem Pharma and Sigma-Aldrich Chemical. He began his career as the Asia-Pacific Sales and Marketing Manager –for Mallinckrodt. He joined the Office of Technology Transfer in 2016.